Tetany due to hypomagnesemia induced by cisplatin and doxorubicin treatment for synovial sarcoma.

Hypocalcemic crisis developed in a patient with monophasic synovial sarcoma after amputation of the right leg, followed by long-term treatment with cisplatin and doxorubicin. Laboratory data revealed severe hypomagnesemia and hypocalcemia. High normal intact parathyroid hormone (PTH), elevated mid-region PTH and undetectable osteocalcin levels had already been found before the appearance of obvious symptoms concomitantly associated with moderate hypomagnesemia and hypocalcemia. Further, both PTH levels measured by two different methods gradually decreased until the initiation of magnesium supplementation. The magnesium supplement immediately relieved the tetany, and induced striking increases in both intact and mid-region PTH levels transiently and continuous elevations of osteocalcin levels. These results suggest that magnesium depletion has dual effects on PTH secretion, from stimulation to inhibition, as hypomagnesemia progresses. Both relative hypoparathyroidism and refractoriness of bone to PTH were thought to be responsible for hypocalcemia due to hypomagnesemia.

[1]  T. Mune,et al.  Production and secretion of parathyroid hormone-related protein in pheochromocytoma: participation of an alpha-adrenergic mechanism. , 1993, The Journal of clinical endocrinology and metabolism.

[2]  E. Ogata,et al.  Hypomagnesemia with increased metabolism of parathyroid hormone and reduced responsiveness to calcitropic hormones. , 1992, Internal medicine.

[3]  S. Epstein.  Serum and urinary markers of bone remodeling: assessment of bone turnover. , 1988, Endocrine reviews.

[4]  A. Brasier,et al.  Recovery of parathyroid hormone secretion after parathyroid adenomectomy. , 1988, The Journal of clinical endocrinology and metabolism.

[5]  Brennan,et al.  Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. , 1987, Clinical chemistry.

[6]  Y. Okimura,et al.  Hypocalcemic crisis in alcoholic fatty liver: transient hypoparathyroidism due to magnesium deficiency. , 1987, The American journal of gastroenterology.

[7]  G. Schulman,et al.  Hypomagnesemic hypocalcemia independent of parathyroid hormone. , 1986, Annals of internal medicine.

[8]  G. Quamme,et al.  Studies on the pathogenesis of cisplatin-induced hypomagnesemia in rats. , 1985, Kidney international.

[9]  R. Bouillon,et al.  MAGNESIUM ADMINISTRATION REVERSES THE HYPOCALCAEMIA SECONDARY TO HYPOMAGNESAEMIA DESPITE LOW CIRCULATING LEVELS OF 25‐HYDROXYVITAMIN D AND 1,25‐DIHYDROXY VITAMIN D , 1985, Clinical endocrinology.

[10]  S. Adami,et al.  HYPOMAGNESAEMIA: STUDIES OF PARATHYROID HORMONE SECRETION AND FUNCTION , 1984, Clinical endocrinology.

[11]  J. Lian,et al.  Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting. , 1984, The Journal of clinical endocrinology and metabolism.

[12]  A. F. Stewart,et al.  Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. , 1982, The New England journal of medicine.

[13]  H. Prentice,et al.  Hypoparathyroidism and hypocalcaemia during treatment for acute leukaemia. , 1982, British medical journal.

[14]  J. Eastwood,et al.  Urinary magnesium leak complicating treatment of choriocarcinoma. , 1982, Nephron.

[15]  S. Marx,et al.  Radioimmunoassay for the middle region of human parathyroid hormone: studies with a radioiodinated synthetic peptide. , 1981, The Journal of clinical endocrinology and metabolism.

[16]  C. Hemalatha,et al.  Cisplatin-induced hypocalcemia and hypomagnesemia. , 1980, Archives of internal medicine.

[17]  P. Price,et al.  Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Schilsky,et al.  Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin. , 1979, Annals of internal medicine.

[19]  J. Tucci,et al.  Metabolic studies in a case of hypocalcemia and osteoblastic metastases. , 1979, Archives of internal medicine.

[20]  F. Singer,et al.  Parathyroid hormone secretion in magnesium deficiency. , 1978, The Journal of clinical endocrinology and metabolism.

[21]  T. Wiegmann,et al.  Hypomagnesemic hypocalcemia. Early serum calcium and late parathyroid hormone increase with magnesium therapy. , 1977, Archives of internal medicine.

[22]  F. Singer,et al.  FUNCTIONAL HYPOPARATHYROIDISM AND PARATHYROID HORMONE END‐ORGAN RESISTANCE IN HUMAN MAGNESIUM DEFICIENCY , 1976, Clinical endocrinology.

[23]  L. Forte,et al.  Impaired release of parathyroid hormone in magnesium deficiency. , 1976, The Journal of clinical endocrinology and metabolism.

[24]  Eisenberg,et al.  Interpretation of Serum Calcium in Patients with Abnormal Serum Proteins , 1973, British medical journal.

[25]  R. Yalow,et al.  Heterogeneity of parathyroid hormone. Clinical and physiologic implications. , 1973, The Journal of clinical investigation.

[26]  A. Tashjian,et al.  Pathogenesis of hypocalcemia in primary hypomagnesemia: normal end-organ responsiveness to parathyroid hormone, impaired parathyroid gland function. , 1973, The Journal of clinical investigation.

[27]  C. Anast,et al.  Evidence for Parathyroid Failure in Magnesium Deficiency , 1972, Science.

[28]  J. B. Williams,et al.  Parathyroid function during chronic magnesium deficiency. , 1972, The Johns Hopkins medical journal.

[29]  L. Sherwood,et al.  Regulation of parathyroid hormone secretion in vitro: quantitative aspects of calcium and magnesium ion control. , 1971, Endocrinology.

[30]  W. A. Shaw,et al.  Hypocalcemia due to hypomagnesemia and reversible parathyroid hormone unresponsiveness. , 1969, The Journal of clinical endocrinology and metabolism.

[31]  H. Rasmussen,et al.  Parathyroid hormone. , 1967, Annual review of physiology.